Complete NUVB Stock Valuation Analysis
Comprehensive intrinsic value analysis using 1 different methodologies
NUVB Peer Valuation Analysis
Relative valuation based on comparable company trading multiples
Peer Valuation Analysis
Fair Value Range Analysis
Based on median multiples from 8 peer companies in Healthcare
P/E Ratio
$-111.84
-4573.5%
Peer Median: 62.5x
EV/EBITDA
$0.00
-100.0%
Peer Median: 45.6x
P/S Ratio
$0.37
-85.4%
Peer Median: 11.3x
Interpretation: Each multiple provides a different perspective on fair value. Consider which multiple is most relevant for NUVB's business model and current situation.
Multiple Comparison
| Multiple | NUVB Current | Peer Median | Peer Average | Premium/Discount | Assessment |
|---|---|---|---|---|---|
| P/E Ratio | -1.4x | 62.5x | 58.9x | -102.2% | Undervalued |
| EV/EBITDA | Infinityx | 45.6x | 45.6x | Infinity% | Overvalued |
| P/S Ratio | 77.4x | 11.3x | 8.0x | 584.2% | Overvalued |
Peer Companies
Click any company to view their valuation
| Company | Market Cap | P/E Ratio | EV/EBITDA | P/S Ratio |
|---|---|---|---|---|
| $0.93B | 55.3x | 50.3x | 11.3x | |
| $0.89B | 0.0x | 0.0x | 0.0x | |
| $1.00B | 0.0x | 0.0x | 0.0x | |
| $0.73B | 0.0x | 0.0x | 3.3x | |
| $0.85B | 0.0x | 0.0x | 77.4x | |
| $0.65B | 0.0x | 0.0x | 2.4x | |
| $0.72B | 0.0x | 0.0x | 0.0x | |
| $729.91B | 62.5x | 45.6x | 14.9x |